GL Outperforms Industry, Trades at a Discount: How to Play the Stock?
Globe Life's premium growth, rising sales, AI initiatives and capital returns support long-term growth as underwriting discipline and investment income strengthen earnings.
GL - Globe Life Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$172.80
DETAILS
HIGH:
$185.00
LOW:
$157.00
MEDIAN:
$175.00
CONSENSUS:
$172.80
DOWNSIDE:
3.46%
Stock News
Buy 5 High ROE Stocks as Markets Get Embroiled in Middle-East Woes
ROST, SUZ, BBVA, GL and AME offer high ROE and cash-rich profiles as investors navigate renewed Middle East tensions.
Globe Life Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
MCKINNEY, Texas, July 8, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its Second Quarter 2026 financial results after the market closes on Wednesday, July 22, 2026. At that time, a copy of the Company's Second Quarter 2026 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website, https://investors.globelifeinsurance.com/, under Financial Reports and Other Financial Information.
Why Globe Life (GL) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
What Makes Globe Life (GL) a Strong Momentum Stock: Buy Now?
Does Globe Life (GL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Globe Life: An Attractive Share Cannibal
Globe Life aggressively reduces share count, prioritizing buybacks over dividends for shareholder returns. GL's disciplined, captive agent model and focus on underserved markets drive steady sales and EPS growth. GL offers 12% upside if growth expectations and valuation normalize.
3 Sales Growth Stocks to Bet on as Markets Remain Resilient
CACI, GL and KNX stand out as sales-growth stocks as resilient markets lean on earnings, AI optimism and a supportive economy.
Maxima Launches Max, A 24/7 Accounting Agent for Enterprise Accounting Teams
SAN MATEO, Calif.--(BUSINESS WIRE)--Maxima, the leading agentic AI platform for enterprise accounting, today announced Max, an AI agent that takes on the manual and recurring preparation work consuming enterprise accounting teams, from payroll entries and opex accruals to balance sheet reconciliations and variance explanations. Max prepares the work and routes it to accountants for review, but nothing posts to the General Ledger (GL) without their approval.Enterprise accounting teams are under u.
5 High ROE Stocks to Buy as Markets Recover After Fed-Induced Sell-Off
ROST, TEL, BBVA, GL and SCHW stand out as high-ROE, cash-rich stocks as markets rebound from the Fed-driven sell-off.
All You Need to Know About Globe Life (GL) Rating Upgrade to Buy
Globe Life (GL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Globe Life (GL) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Globe Life (GL) is a Great Momentum Stock to Buy
Does Globe Life (GL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Globe Life Hits 52-Week High: Time to Add the Stock for Solid Returns?
GL is benefiting from premium growth, rising investment income and strong sales momentum across its insurance businesses.
These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
Despite a whiplash-inducing correction following the start of the Iran war, the S&P 500 is now up around 10% year-to-date (YTD). But the rally has been narrow, and the market has become sharply divided between stocks with AI connections and those without, which puts the insurance sector in perilous territory.
Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Buy 5 Stocks With High ROE as Markets Swing on War Skirmishes
ROST joins TEL, CVE, GL and SCHW high-ROE cash cows screened for $1B+ cash flow as markets whip on Iran-U.S. skirmishes.
Morgan Stanley And Two Insurance Stocks Hit New Highs
Morgan Stanley stock is in a buy zone of a base. A biometric identity name hit a new high after rebounding following a sell signal.
Globe Life (GL) Up 1.7% Since Last Earnings Report: Can It Continue?
Globe Life (GL) reported earnings 30 days ago. What's next for the stock?
5 Stocks to Watch From Prospering Accident & Health Insurance Industry
Accident and Health Insurance stocks like AFL, UNM, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
Why Globe Life (GL) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Price Targets
Globe Life price target raised to $166 from $147 at Jefferies
$166.00
(was $178.86)
Jefferies
Globe Life price target raised to $175 from $167 at Piper Sandler
$175.00
(was $156.28)
Piper Sandler
Globe Life price target raised to $181 from $176 at Morgan Stanley
$181.00
(was $155.30)
Morgan Stanley
Globe Life price target raised to $185 from $180 at Truist
$185.00
(was $153.55)
Mark Hughes
·
Truist Financial
Globe Life price target raised to $157 from $155 at Evercore ISI
$157.00
(was $144.86)
Evercore ISI
Globe Life price target lowered to $176 from $177 at Morgan Stanley
$176.00
(was $140.82)
Bob Huang
·
Morgan Stanley
Piper Sandler Reiterates Overweight Rating on Globe Life (GL)
$167.00
(was $133.61)
John Barnidge
·
Piper Sandler
Globe Life price target raised to $158 from $150 at Truist
$158.00
(was $134.49)
Mark Hughes
·
Truist Financial
Globe Life price target raised to $179 from $171 at Morgan Stanley
$179.00
(was $134.91)
Bob Huang
·
Morgan Stanley
Globe Life upgraded to Overweight from Equal Weight at Morgan Stanley
$166.00
(was $139.51)
Morgan Stanley
Globe Life price target raised to $127 from $125 at Morgan Stanley
$127.00
(was $119.38)
Bob Huang
·
Morgan Stanley
Globe Life price target raised to $126 from $125 at Morgan Stanley
$126.00
(was $127.43)
Morgan Stanley
Globe Life price target raised to $188 from $160 at Raymond James
$188.00
(was $109.77)
Wilma Burdis
·
Raymond James
Evercore ISI Reiterates In Line Rating on Globe Life (GL)
$95.00
(was $104.40)
Thomas Gallagher
·
Evercore ISI
Globe Life price target raised to $90 from $80 at Truist
$90.00
(was $90.25)
Mark Hughes
·
Truist Financial
CFRA Upgrades Globe Life (GL) to Hold
$92.00
(was $90.30)
Catherine Seifert
·
CFRA
Globe Life (GL) PT Raised to $106 at Piper Sandler
$106.00
(was $90.48)
John Barnidge
·
Piper Sandler
Globe Life price target raised to $65 from $62 at Morgan Stanley
$65.00
(was $81.91)
Bob Huang
·
Morgan Stanley
Globe Life price target raised to $90 from $88 at Jefferies
$90.00
(was $81.91)
Suneet Kamath
·
Jefferies
Globe Life (GL) PT Lowered to $110 at Piper Sandler
$110.00
(was $82.00)
John Barnidge
·
Piper Sandler